Smoking, the missing drug interaction in clinical trials: ignoring the obvious.

@article{Gritz2005SmokingTM,
  title={Smoking, the missing drug interaction in clinical trials: ignoring the obvious.},
  author={Ellen R. Gritz and Carolyn M. Dresler and Linda P Sarna},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2005},
  volume={14 10},
  pages={2287-93}
}
Tobacco use is universally recognized as the foremost preventable cause of cancer in the United States and globally and is responsible for 30% of all cancer-related deaths in the United States. Tobacco use, including exposure to secondhand smoke has been implicated as a causal or contributory agent in an ever-expanding list of cancers, including lung, oral cavity and pharynx, pancreas, liver, kidney, ureter, urinary bladder, uterine cervix, and myeloid leukemia. In addition to and independent… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 72 extracted citations

Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association • 2014
View 1 Excerpt
Highly Influenced

Monitoring smoking behaviour using a wearable acoustic sensor

2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) • 2017
View 1 Excerpt

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016

References

Publications referenced by this paper.
Showing 1-10 of 96 references

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2001
View 5 Excerpts
Highly Influenced

Treating tobacco use and dependence in clinical practice.

Expert opinion on pharmacotherapy • 2006
View 4 Excerpts
Highly Influenced

TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2004
View 4 Excerpts
Highly Influenced

Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer.

The New England journal of medicine • 1993
View 4 Excerpts
Highly Influenced

: a study of absolute and relative survival over 15 years

JO Ebbert, BA Williams, Z Sun
lung cancer • 2005

Similar Papers

Loading similar papers…